Xzzchronopharmaceutics: A promising drug delivery finding of the last two decades

Recent Patents on Drug Delivery and Formulation

Volumn 4, Issue 2, 2010, Pages 129-144

  Ali, Javed ^a,b   Saigal, Nitin ^a,b   Qureshi, Mohd J ^a,b   Baboota, Sanjula ^a,b   Ahuja, Alka ^a,b  

^a HAMDARD UNIVERSITY   (India)

^b Jubilant Organosys   (India)

Author keywords

Chronomodulation; Circadian rhythm; Erodible system; Lag time; Pulsatile systems; Rupturable system; Stimuli sensitive system; Swellable system

Indexed keywords

4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; ALGINIC ACID; AMOXICILLIN; AMOXICILLIN PULSYS; CAPTOPRIL; CELLACEFATE; DILTIAZEM; EUDRAGIT; GLYCINE ETHYL ESTER; INSULIN; LIPOSOME; MACROGOL; METHYLPHENIDATE; MICROSPHERE; NIFEDIPINE; POLY(N ISOPROPYLACRYLAMIDE); POLYANHYDRIDE; POLYCARBONATE; POLYGLACTIN; POLYLACTIC ACID; POLYMETHACRYLIC ACID; POLYSTYRENE; PROPRANOLOL; SALBUTAMOL SULFATE; SHELLAC; THEOPHYLLINE; UNCLASSIFIED DRUG; VERAPAMIL; VERELAN PM; DRUG;

AREA UNDER THE CURVE; ARTICLE; ATTENTION DEFICIT DISORDER; BIODEGRADABILITY; CHRONOBIOLOGY; CIRCADIAN RHYTHM; DRUG ABSORPTION; DRUG CAPSULE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG PELLET; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG SOLUBILITY; DRUG TARGETING; ELECTROSTIMULATION; FIRST PASS EFFECT; GLYCEMIC CONTROL; HUMAN; HYDROGEL; HYDROPHILICITY; HYDROPHOBICITY; INFLAMMATION; MAGNETIC STIMULATION; MAXIMUM PLASMA CONCENTRATION; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; MICELLE; NONHUMAN; OSMOSIS; OSMOTIC PUMP; PATENT; PRIORITY JOURNAL; PULSATILE DRUG RELEASE; TABLET; TABLET FORMULATION; TEMPERATURE SENSITIVITY; TIME TO MAXIMUM PLASMA CONCENTRATION; ULTRASOUND; ANIMAL; CHEMISTRY; CHRONOTHERAPY; DELAYED RELEASE FORMULATION; DRUG PULSE THERAPY; METABOLISM; METHODOLOGY; REVIEW;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG CHRONOTHERAPY; DRUG DELIVERY SYSTEMS; HUMANS; PATENTS AS TOPIC; PHARMACEUTICAL PREPARATIONS; PULSE THERAPY, DRUG;

EID: 77954063534     PISSN: 18722113     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221110791184962     Document Type: Article

References (99)

1. Bjorn Lemmer. Circadian rhythms and drug delivery. J Control Release 1991; 16: 63-74.
2. Anil K. Anal. Time controlled pulsatile drug delivery system for bioactive compounds. Recent Pat Drug Deliv Form 2007; 1: 73-9.
3. Nitin Saigal, Sanjula Baboota, Alka Ahuja, Javed Ali. Site specific chronotherapeutic drug delivery systems: A patent review. Recent Pat Drug Deliv Form 2009; 3: 64-70.
4. Bussemer T, Otto I, Roland Bodmeier. Pulsatile drug delivery system. Crit Rev Ther Drug Carrier Syst 2001; 18: 433-58.
5. Gurny R, Junginger H. E, Nicholas A. Peppas. Pulsatile drug delivery: Current application and future trends. Stuttgart, Germany 1993; Wissenschaftliche.
6. Andreas Linkwitz, Judy A. Magruder, Sonya Merrill. Osmotically driven delivery device with expandable orifice for pulsatile delivery effect. US5318558 (1994).
7. Yoshio Ueda, Takehisa Hata, Hisami Yamaguchi, Satoshi Ueda, Masateru Kodani. Time-controlled explosion systems and processes for preparing the same. US4871549 (1989).
8. Stephen M. Balaban, James B. Pike, Jonathon P. Smith, Clifton A. Baile. Osmotically driven delivery devices with pulsatile effect. US5209746 (1993).
9. Stephen M. Balaban, James B. Pike, Jonathon P. Smith, Clifton A. Baile. Delivery devices with pulsatile effect US5308348 (1994).
10. Marion E. McNeill, Abdul Rashid, Stevens Howard. Dispensing device. US5342624 (1994).
11. Saeger H, Virley P. Pulsincap & Mac 226. Pulsed-release dosage form. Product information from Scherer DDS Ltd 2004.
12. Wilding IR, Davis SS, Bakhshaee M, Stevens HNE, Sparrow RA, Brennan J. Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation. Pharm Res 1992; 9: 654-7.
13. Ina Krogel, Roland Bodmeir. Evaluation of an enzyme containing capsular shaped pulsatile drug delivery system. Pharm Res 1999; 16: 1424-9.
14. Kiyoshi Niwa, Tomohiro Takaya, Tsuyoshi Morimoto, Kanji Takada. Preparation and evaluation of a time-controlled release capsule made of ethyl cellulose for colon delivery of drugs. J Drug Target 1995; 3: 83-9.
15. Ganiyu A. Jimoh, Donald L. Wise, Joseph D. Gresser, Debra J. Trantolo. Pulsed FSH release from an implantable capsule system. J Control Release 1995; 34: 87-95.
16. Rupal Ayer. Osmotic delivery system with membrane plug retention mechanism. US20010021822 (2001).
17. Kamal K. Midha, Theodore L. Iorio, Shubha Chungi. Pharmaceutical dosage form for pulsatile delivery of methylphenidate. US6340476 (2002).
18. Crison JR, Siersma PR, Taylor MD, Amidon GL. Programmable oral release technology, Port system & Mac 226: A novel dosage form for time and site specific oral drug delivery. Proc Int Symp Control Release Bioact Mater 1995; 22: 278-9.
19. Gary R. Kelm, Gary L. Manring. Pharmaceutical dosage form for colonic delivery. US5814336 (1998).
20. Jiang HL, Zhu KJ. Pulsatile protein release from a laminated device comprising of polyanhydride and pH-sensitive complexes. Int J Pharm 2000; 194: 51-60.
21. Mooter G. Vanden. Azo polymer for colon specific drug delivery. Int J Pharm 1992; 87: 37-44.
22. John NC. Healy. Enteric coatings and delayed release. In: Ellis Horwood, drug delivery to the gastrointestinal tract. Chichester 1989; 456-80.
23. Peter Watts. Colonic drug delivery composition. US6228396 (2001).
24. Li Y. Qui, Ke-Jia Zhao. Design of core-shelled polymer cylinder for potential programmable drug delivery. Int J Pharm 2001; 219:151-8.
25. Frederick Maruyama, Richard Cortese. Multi-unit pulsatile delivery system. US5017381 (2001).
26. Alessandra Maroni, Lucia Zema, Matteo Cerea, Maria E. Sangalli. Oral Pulsatile drug delivery systems. Expert Opin. Drug Delv 2001; 2: 855-71.
27. Pozzi F, Furlani P, Gazzaniga A, Davis SS, Wilding IR. The Time Clock system: A new oral dosage form for fast and complete release of drug after a predetermined lag time. J Control Release 1994; 31: 99-108.
28. Ubaldo Conte, Busto Arsizio, La A. Manna, Paolo Comolobo. Tablet for pharmaceutical use able to release active substances at successive times. US4865849 (1989).
29. Gazzaniga A, Busetti C, Moro L, Crimella T, Sangalli ME, Giordano F. Evaluation of low viscosity HPMC as retarding coating material in the preparation of time based oral colon specific delivery system. Proc Int Symp Control Release Bioact Mater 1995; 22: 242-3.
30. Noda K, Osawa T, Takahata H, Maejima T, Kobayashi M. Sigmoidal releasing system (SRS) as a novel oral controlled release formulation. Proc Int Symp Control Release Bioact Mater 1991; 18: 405-6.
31. Ishino R, Yoshino H, Hirakawa Y, Noda K. Design and preparation of pulsatile release tablet as a new oral drug. Chem Pharm Bull 1992; 40: 3036-41.
32. Ishino R, Yoshino H, Hirakawa Y, Noda K. Absorption of diltiazem in beagle dog pulsatile release tablet. Chem Pharm Bull 1992; 40: 3094-6.
33. Fan TY, Wei SL, Yan WW, Chen D, Li J. An investigation of pulsatile release tablets with ethylcellulose and Eudragit L as film coating materials and cross-linked polyvinylpyrrolidine in the core tablets. J Control Release 2001; 77: 245-51.
34. Adel Penhasi, Moshe Flashner, Itzhak E. Lerner. Delayed total release two pulse gastrointestinal drug delivery system. US6632451B2 (2003).
35. Kamal K. Midha. US6555136 (2003).
36. Adel Penhasi, Moshe Flashner, Itzhak E. Immediate release gastrointestinal drug delivery system. US6531152B1 (2003).
37. Patrick S. Wong, Felix Theeuwes, James B. Eckenhoff, Steven D. Larsen, Hoa T. Huynh. Multi-unit delivery system. US5110597 (1992).
38. Chih-Ming Chen. Pulsatile particles drug delivery system. US5472708 (1995).
39. Chih-Ming Chen. Multiparticulate pulsatile drug delivery system. US5260068 (1993) and US5260069 (1993).
40. Phillip J. Percel, Krishna S. Vishnupad, Gopi M. Venkatesh, Der Y. Lee. Timed pulsatile drug delivery systems. US7048945B2 (2006).
41. Gohel MC, Sumitra M. Modulation of active pharmaceutical material release from a novel tablet in capsule system containing an effervescent blend. J Control Release 2002; 79: 157-64.
42. Krogel I, Bodmeier R. Floating or pulsatile drug delivery systems based on coated effervescent cones. Int J Pharm 1999; 187: 175-84.
43. Jane P. Bai. Pulsatile drug delivery system. US5840329 (1998).
44. Peter Schultz, Peter Kleinebudde. A new multiparticulate delayed release system. Part I: Dissolution properties and release mechanism. J Control Release 1997; 47: 181-9.
45. Peter Schultz, Ingunn Tho, Peter Kleinebudde. A new multiparticulate delayed release system. Part II: Coating formulation and properties of free films. J Control Release 1997; 47: 191-9.
46. Barr, I.G., Thiel, W.J. Single dose vaccination system. US5840329 (1997).
47. Roland Bodmeier, Guo X, Sarabia R.E, Skultety P. The influence of buffer species and strength on diltiazem HCl release from beads coated with aqueous cationic polymer dispersions, Eudragit RS, RL 30D. Pharm Res 1996; 13: 52-6.
48. Beckert TE, Pogarell K, Hack I, Petereit HU. Pulsed drug release with film coatings of Eudragit & Mac226; RS 30D. Proc Int Symp Control Rel Bioact Mater 1999; 26: 533-4.
49. Narisawa S, Nagata M, Ito T, Yoshino H, Hirakawa Y, Noda K. Drug release behavior in gastrointestinal tract of beagle dogs from multiple unit type rate-controlled or time-controlled release preparations coated with insoluble polymer-based film. J Control Release 1995; 33: 253-60.
50. Guo, X. Physicochemical and mechanical properties influencing the drug release from coated dosage forms. Doctoral Thesis 1996. The University of Texas at Austin.
51. Ishihara K, Kobayashi M, Shinohara I. Control of insulin permeation through a polymer membrane with responsive function for glucose. Makromol Chem Rapid Commun 1983; 4: 327-31.
52. Horbett TA, Kost J, Ratner BD, Sungh M. Glucose sensitive membrane containing glucose oxidase: Activity, swelling and permeability studies. J Biomed Mater Res 1985; 19: 1117-1133.
53. Horbett TA, Albin G, Ratner BD. Glucose sensitive membrane for controlled delivery of insulin: Insulin transport studies. J Control Release 1985; 2: 153-64.
54. Kim SW, Makino K, Mack EJ, Okano T. A microcapsule self regulating delivery system for insulin. J Control Release 1990; 12: 235-9.
55. Kim SW, Pai CM, Makino K, Seminoff LA, Holmberg DL, Gleeson JM, Wilson DE, Mack E J. Self regulated glycosylated insulin delivery. J Control Release 1990; 11: 193-201.
56. Obaidat AA, Park K. Characterization of protein release through glucose sensitive hydrogel membrane. Biomaterials 1997; 18 (11): 801-6.
57. Okano T, Kitano S, Koyama Y, Hisamitsu I, Kataoka K, Sakurai Y. A novel drug delivery system utilizing a glucose responsive polymer between polyvinyl alcohol and Poly (N-vinyl-2-pyrrolidone) with a phenyl boronic acid moiety. J Control Release 1992; 19: 162-70.
58. Kitano S, Hisamitsu I, Koyama Y, Kataoka K, Sakurai Y. Effect of the incorporation of amino groups in a glucose responsive polymer complex having phenylboronic acid moieties. Polym Adv Technol 1991; 2: 261-4.
59. Shino D, Murata Y, Kataoka K, Yokuyama M, Okano T, Sakurai Y. Preparation and characterization of a glucose responsive insulin releasing polymer device. Biomaterials 1994; 15: 121-8.
60. Shino D, Murata Y, Kataoka K, Yokuyama M, Okano T, Sakurai Y. A self regulated insulin delivery system using boronic acid gels. J Intell Mater Syst Struc 1994; 5: 311-4.
61. Shino D, Murata Y, Kataoka K, Yokuyama M, Okano T, Sakurai Y, Murata Y, Kikuchi A. Amine containing phenyl acid gel for glucose responsive insulin release under physiological pH. J Control Release 1995; 37: 269-76.
62. Kataoka K, Shino D, Murata Y, Yokuyama M, Okano T, Sakurai Y. A self regulated insulin delivery system using boronic acid gels. J Intell Mater Syst Struc 1994; 5: 311-4.
63. Yui N, Okano T, Sakurai Y. Inflammation responsive degradation of cross linked Hyaluronic acid gels. J Control Release 1992; 22: 105-16.
64. Yui N, Nihira J, Okano T, Sakurai Y. Regulated release of drug microspheres from inflammation responsive degradable matrices of crosslinked hyaluronic acid. J Control Release 1993; 25: 133-43.
65. Miyata T, Asami N, Urgami T. A reversibly antigen responsive hydrogel. Nature 1999; 399: 766-9.
66. Miyata T, Asami N, Urgami T. Preparation of an antigen sensitive hydrogel using antigen antibody bindings. Macromolecules 1999; 32: 2082-4.
67. Kishi M, Hara M, Sawahata K, Osada Y. Conversion of chemical in to mechanical energy by synthetic polymer gels (chemomechanical system). In: Polymer gels-Fundamental and biomedical application. Plenum Press, New York 1991; 205-20.
68. Kwon IC, Bae YH, Okano T, Berner B, Kim SW. Stimuli sensitive polymers for drug delivery systems. Makromol Chem Macromol Symp 1990; 33: 265-7.
69. Kwon IC, Bae YH, Okano T, Berner B, Kim SW. Drug release from electric current sensitive polymers. J Control Rel 1991; 17: 149-56.
70. Kwon IC, Bae YH, Okano T, Berner B, Kim SW. Electrically erodible polymer gel for controlled release of drug. Nature 1991; 354: 291-3.
71. D'Emanuele A, Staniforth JN. Feedback controlled drug delivery using electro diffusion pump. J Control Rel 1993; 23: 97-104.
72. Levy D, Kost J, Meshulam Y, Langer R. Effect of ultrasound on transdermal drug delivery to rats and guinea pigs. J Clin Invest 1989; 83: 2074-8.
73. Kost J. Ultrasound for controlled delivery of therapeutics. Clin Mater 1993; 13: 155-61.
74. Machluf M, Kost J. Ultrasonically enhanced transdermal drug delivery. Experimental approachesto elucidatethe mechanism. J Biomater Sci Polym 1993; 5: 147-56.
75. Mitragotri S, Blankschetein D, Langer R. Ultrasound mediated transdermal protein delivery. Science 1995; 269: 850-3.
76. Mitragotri S, Blankschetein D, Langer R. Transdermal drug delivery using low frequency sonophoresis. Pharm Res 1996; 13: 411-20.
77. Byl NN. The use of ultrasound as an enhancer for transdermal drug delivery. Pharm Res 2000; 17: 1354-9.
78. Kost J, Leong L, Langer R. Ultrasound enhanced polymer degradation and release of incorporated substances. Proc.Natl Acad Sci USA 1989; 86: 7663-6.
79. Supersaxo A, Kou J.H, Teitelbaum P, Maskiewicz R. Performed porous microspheres for controlled and pulsed release of macromolecule. J Control Release 1993; 23: 157-64.
80. Kwok CS, Mourad PD, Crum LA, Ratner BD. Self assembled molecular structure as ultrasonically responsive barrier membrane for pulsatile drug delivery. J Biomed Mater Res 2001; 57: 151-64.
81. Moriyama K, Ooya T, Yui N. Pulsatile peptide release from multilayered hydrogel formulation consisting of poly (ethylene glycol) grafted and ungrafted dextrans. J Biomater Sci.Polym Ed 1999; 12: 1251-64.
82. Moriyama K, Ooya T, Yui N. Hyaluronic acid grafted with poly (ethylene glycol) as a noel peptide formulation. J Control Rel 1999; 59: 1251-64.
83. Langer R, Edelmen ER, Kost J, Bobeck H. Regulation of drug release from polymer matrices by oscillating magnetic field. J Biomed Mater Res 1985; 19: 67-83.
84. Kost J, Noecker R, Kunica E, Langer R. Magnetically controlled release system Effect of polymer composition. J Biomed Mater Res 1985; 19: 935-940.
85. Yoshida R, Okano T, Yui N, Yokuyama M. Advances in polymeric system for drug delivery, Gordon Breach: Yverdon, Switzerland 1994.
86. Bae YH, Okano T, Kim SW. 'On-off' thermocontrol of solute transport. I. Temperature dependence of swelling of N-isopropylavrylamide networks modified with hydrophobic components in water. Pharm Res 1991; 8: 531-7.
87. Bae YH, Okano T, Kim SW. 'On-off' thermocontrol of solute transport. II. Solute release from thermosensitive hydrogels. Pharm Res 1991; 8: 624-8.
88. Bae YH, Okano T, Jacobs H, Kim SW. Thermally on-off switching polymers for drug permeation and release. J Control Release 1990; 11: 255-65.
89. Yoshida R, Uchida K, Kaneko Y, Sakai K, Kikuchi A, Sakurai T, et al. Comb type grafted hydrogel with rapid temperature response. Nature 1995; 374: 240-4.
90. Kaneko Y, Yoshda R, Sakai K, Kikuchi A, Sakurai T, Okano T. Influence of freely soluble grafted chains length on dynamic property of comb type grafted poly (N-isopropylacrylamide) hydrogels. Macromolecules 1995; 28: 7717-23.
91. Kaneko Y, Sakai K, Kikuchi A, Sakurai T, Okano T. Fast swelling /deswelling kinetics of comb type grafted poly (N-isopropylacrylamide) hydrogels. Macromol Chem Macromol Symp 1996; 109: 41-53.
92. Kaneko Y, Nakamura S, Aoyagi T, Sakai K, Kikuchi A, Sakurai T, Okano T. Rapid deswelling response of poly (N-isopropylacrylamide) hydrogels by the formation of water release channels using poly (ethyleneoxide) graft chains. Macromolecules 1998; 31: 6099-105.
93. Matasumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986; 46: 6387-92.
94. Chung J.E, Yokuyama M, Yamato M, Aoyagi T, Sakurai Y, Okano T. Thermoresponsive drugdelivery from polumeric micelles constructed using block copolymers of poly (N-isopropylacrylamide) and poly (butylmethacrylate). J Control Release 1999; 62: 115-27.
95. Chung J.E, Yokuyama M, Okano T. Inner core segment design for drug delivery control of thermoresponsive polymeric micelles. J Control Release 2000; 65: 93-103.
96. Kohori F, Sakai K, Aoyagi T, Yokuyama M, Sakurai Y, Okano T. Preparation and characterization of thermally responsive block copolymer micelles comprising poly (N-isopropylacrylamide- - DL- lactide). J Control Release 1998; 55: 87-98.
97. Okano T, Kitano S, Koyama Y, Kataoka K, Sakurai Y. Glucose responsive complex formation between poly (vinyl alcohol) and Poly (N-vinyl 2-pyrrolidone) with pendent phenyl boronic acid moieties. Makromol Chem Rapid Commun 1999; 12: 227-33.
98. Kohori F, Sakai K, Aoyagi T, Yokuyama M, Sakurai Y, Okano T. Control of adriamycin cytotoxic activity using thermally responsive block co polymer micelles composed of poly(N-isopropylacryl-amide-coN,N dimethylacrylamide)-- - poly (DL-lactide). Colloids surfaces B: Biointerfaces 1999; 16: 195-205.
99. Nitin Saigal, Sanjula Baboota, Alka Ahuja, Javed Ali. Multiple pulse drug delivery system: Setting a new paradigm for infectious disease therapy. Exp Opin Dru Deliv 2009; 6(4); 441-52.